表紙
市場調查報告書

深層腦部刺激器市場 - 成長,趨勢,及預測(2019年 - 2024年)

Deep Brain Stimulation Devices Market - Growth, Trends, and Forecast (2019 - 2024)

出版商 Mordor Intelligence LLP 商品編碼 866757
出版日期 內容資訊 英文 112 Pages
商品交期: 2-3個工作天內
價格
Back to Top
深層腦部刺激器市場 - 成長,趨勢,及預測(2019年 - 2024年) Deep Brain Stimulation Devices Market - Growth, Trends, and Forecast (2019 - 2024)
出版日期: 2019年05月01日內容資訊: 英文 112 Pages
簡介

本報告提供全球深層腦部刺激器市場的相關調查,市場概況,各成長要素、阻礙因素,產品、用途、終端用戶、地區的市場分析,競爭情形,主要企業的簡介等資訊彙整。

目錄

第1章 簡介

  • 研究成果
  • 調查的前提條件
  • 調查範圍

第2章 調查方法

第3章 摘要整理

第4章 市場動態

  • 市場概況
  • 市場成長要素
    • 急速增多的高齡人口帶來神經疾病的風險與高罹患率
    • 由於微創治療的人氣高漲對設備高需求
    • 技術性進步的深層腦部刺激器的效用
  • 市場阻礙因素
    • 深層腦部刺激器相關的風險
    • 帶給市場不良影響的政府的政策的實施
  • 波特五力分析
    • 新加入廠商的威脅
    • 買主/消費者談判力
    • 供應商談判力
    • 替代產品的威脅
    • 產業內的競爭

第5章 市場區隔

  • 各產品類型
    • 單通道深層腦部刺激器
    • 雙通道深層腦部刺激器
  • 各用途
    • 帕金森氏症
    • 原發性顫抖症
    • 強迫性精神官能症
    • 癲癇
    • 肌張力不全症
    • 其他
  • 各終端用戶
    • 醫院
    • 門診病人手術中心
    • 神經科診所
    • 其他
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東及非洲
    • 南美

第6章 競爭情形

  • 企業簡介
    • Abbott Laboratories (St Jude Medical)
    • Beijing PINS Medical Co., Ltd.
    • Boston Scientific Corporation
    • Fisher Wallace
    • Functional Neuromodulation, Ltd
    • Medtronic Plc
    • NeuroPace Inc.
    • Renishaw plc

第7章 市場機會及將來趨勢

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 64165

Market Overview

The major factors for the growth of the deep brain stimulation devices market include the rapidly aging population leading to risk and high prevalence of neurological disorders, growing demand for the devices due to the rising popularity of minimally invasive procedures, and availability of technologically advanced deep brain stimulation devices.

Deep Brain Stimulation (DBS) is a widely used treatment for the advanced Parkinson's disease (PD), essential tremor, and dystonia, and its clinical applications. However, in addition to the extension of the clinical applications of DBS over the last three decades, there has been tremendous growth in technology. Therefore, the advent of competition in the DBS industry has led to a surge of innovative technologies. Currently, there are multiple DBS systems that are approved by the European and US regulatory agencies. The US Food and Drug Administration (FDA) has recently approved Boston Scientific Corporation's Vercise Deep Brain Stimulation (DBS) System. This DBS system is used to treat the symptoms of Parkinson's disease (PD). Therefore, researchers are also improving their existing DBS systems, while developing the next generation of devices. The researchers are targeting DBS to different areas of the brain and studying the treatment in different populations of people living with Parkinson's. Although, some changes in the new systems have shown improvement in clinical outcomes. Nevertheless, these new developments in DBS technology are encouraging a large patient community and to the health care providers. Hence, all these new advancements in the technologies have to lead to an increase in the deep brain stimulation devices market.

Scope of the Report

As per the scope of this report, deep brain stimulator is a battery-operated medical device called neurostimulator, used in the neurosurgical procedure, which helps to treat a variety of disabling neurological symptoms. The market is segmented by product type, application, end user, and geography.

Key Market Trends

Parkinson's Disease is the Segment by Application is expected to Dominate the Market

The major factor driving the growth of the segment is the rising prevalence of Parkinson's diseases across the globe. According to Parkinson's news in 2018, approximately 1.2 million people in the United States are predicted to have Parkinson's disease by the year 2030. It is the second-most common neurodegenerative disorder in the United States. Similarly, as per the estimates of the NHS UK, Parkinson's disease is found affecting around 1 in 500 people, which means there are an estimated 127,000 people in the UK with the condition. In addition, there are thousands of patients who go undetected. DBS is the most commonly performed surgical treatment for Parkinson's. It is usually done in people who have had Parkinson's for at least four years and still get a benefit from medication but have motor complications. Furthermore, there is a rising technological advancement is going on in the field of DBS propelling overall growth of the market.

North America is Expected to Dominate the Market

According to the Parkinson's Foundation Prevalence Project, 930,000 people in the United States will be living with Parkinson disease by the year 2020. The combined direct and indirect costs of Parkinson's in the United States, including treatment, disability, and similar costs, plus lost income from an inability to work, are estimated at USD 25 billion per year in the United States alone. Hence, a growing burden of Parkinson's disease on the healthcare system coupled with uncertain economic conditions in the United States has forced the Original Equipment Manufacturers (OEMs) to develop cost-effective devices for the treatment of neurological movement disorders. The US Food and Drug Administration (FDA) has also approved another deep brain stimulation (DBS) device in 2015, for treatment of Parkinson's disease and essential tremor. The Brio System's approval has been good news for the Parkinson's patient community in the market, as it may stimulate more rapid development of DBS technology. Boston Scientific Corporation has received approval from the US Food and Drug Administration (FDA) in Dec 2017, for the Vercise Deep Brain Stimulation (DBS) System. Hence, all these recent product approvals and growing incidences of the Parkinson's disease have helped in driving the Deep Brain Stimulation Devices Market.

Competitive Landscape

The market studied is a consolidated market owing to the presence of the few major market players. Some of the market players are Abbott Laboratories (St Jude Medical), Beijing PINS Medical Co., Ltd., Boston Scientific Corporation, Fisher Wallace, Functional Neuromodulation, Ltd, Medtronic Plc, NeuroPace Inc., and Renishaw plc

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rapidly Aging Population Leading to Risk and High Prevalence of Neurological Disorders
    • 4.2.2 Growing Demand for the Devices due to Rising Popularity of Minimally Invasive Procedures
    • 4.2.3 Availability of Technologically Advanced Deep Brain Stimulation Devices
  • 4.3 Market Restraints
    • 4.3.1 Risks Associated with Deep Brain Stimulation Procedures
    • 4.3.2 Implementation of the Government Policies Negatively Affecting the Market
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product Type
    • 5.1.1 Single Channel Deep Brain Stimulator
    • 5.1.2 Dual Channel Deep Brain Stimulator
  • 5.2 By Application
    • 5.2.1 Parkinson's Disease
    • 5.2.2 Essential Tremor
    • 5.2.3 Obsessive Compulsive Disorder
    • 5.2.4 Epilepsy
    • 5.2.5 Dystonia
    • 5.2.6 Other
  • 5.3 By End User
    • 5.3.1 Hospitals
    • 5.3.2 Ambulatory Surgical centers
    • 5.3.3 Neurological Clinics
    • 5.3.4 Other
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 US
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 UK
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Argentina

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott Laboratories (St Jude Medical)
    • 6.1.2 Beijing PINS Medical Co., Ltd.
    • 6.1.3 Boston Scientific Corporation
    • 6.1.4 Fisher Wallace
    • 6.1.5 Functional Neuromodulation, Ltd
    • 6.1.6 Medtronic Plc
    • 6.1.7 NeuroPace Inc.
    • 6.1.8 Renishaw plc

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top